Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Lederer

Showing results (161-170 of 219) with videos related to

Pageof 22
Sort By:
Chest|February 26, 2011
Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosisMichael W Sims, Michael F Beers, Vivek N Ahya, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 17, 2016
Adipose Gene Expression Profile Changes With Lung Allograft ReperfusionJoshua M Diamond, Selim Arcasoy, Jamiela A McDonnough, et al.
Chest|February 23, 2013
Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantationRupal J Shah, Joshua M Diamond, Edward Cantu, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
American Journal of Respiratory and Critical Care Medicine|June 17, 2014
Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantationRupal J Shah, Amir M Emtiazjoo, Joshua M Diamond, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 4, 2022
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstructionNicola A Hanania, Mario Castro, Eric Bateman, et al.
Annals of the American Thoracic Society|March 2, 2017
Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary FibrosisAni Manichaikul, Li Sun, Alain C Borczuk, et al.
Thorax|March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2023
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthmaDaniel J Jackson, Leonard B Bacharier, Wanda Phipatanakul, et al.
The Lancet. Respiratory Medicine|November 13, 2023
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension studyLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.
Pageof 22

Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Chest|February 26, 2011
Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosisMichael W Sims, Michael F Beers, Vivek N Ahya, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 17, 2016
Adipose Gene Expression Profile Changes With Lung Allograft ReperfusionJoshua M Diamond, Selim Arcasoy, Jamiela A McDonnough, et al.
Chest|February 23, 2013
Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantationRupal J Shah, Joshua M Diamond, Edward Cantu, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
American Journal of Respiratory and Critical Care Medicine|June 17, 2014
Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantationRupal J Shah, Amir M Emtiazjoo, Joshua M Diamond, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 4, 2022
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstructionNicola A Hanania, Mario Castro, Eric Bateman, et al.
Annals of the American Thoracic Society|March 2, 2017
Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary FibrosisAni Manichaikul, Li Sun, Alain C Borczuk, et al.
Thorax|March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2023
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthmaDaniel J Jackson, Leonard B Bacharier, Wanda Phipatanakul, et al.
The Lancet. Respiratory Medicine|November 13, 2023
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension studyLeonard B Bacharier, Jorge F Maspero, Constance H Katelaris, et al.
Pageof 22